UNITEDHEALTH GROUP

Shareholders of UnitedHealth Group Incorporated

UnitedHealth Group Incorporated is listed on the New York Stock Exchange under the ticker UNH, with a share register dominated by institutional asset managers rather than a small number of controlling holders. Under U.S. securities law, only investors whose beneficial ownership crosses 5% of a class of stock must publicly disclose their holdings, via a Schedule 13G or 13G/A filed with the SEC; the majority of UnitedHealth Group Incorporated’s outstanding shares are held by investors below this threshold and are not individually named in public filings. Among disclosed major holders, BlackRock, Inc. reported beneficial ownership of approximately 7.8% of UnitedHealth Group Incorporated’s common stock (72,595,811 shares) in a Schedule 13G/A filed with the SEC on 6 February 2024. Vanguard’s reporting structure changed in January 2026, when certain Vanguard entities began filing beneficial-ownership disclosures separately rather than through a single consolidated filer; one such entity, Vanguard Capital Management, reported holding 7.50% of UnitedHealth Group Incorporated’s common stock (68,122,483 shares) as of 31 March 2026, though a single up-to-date combined percentage across all Vanguard-affiliated holders could not be independently confirmed from primary filings at the time of writing.

Data availability

Disclosure is major shareholders only: publicly available filings identify holders that have crossed the SEC’s 5% reporting threshold, not the complete shareholder base of a widely held NYSE-listed company. Ownership percentages and holder names shown elsewhere in this profile could not be independently reconciled against the primary SEC filings cited below and should be treated with caution.

Sources

• BlackRock, Inc., Schedule 13G/A, UnitedHealth Group Incorporated, filed with the SEC 6 February 2024 — sec.gov EDGAR (CIK 0000731766) — retrieved 11 September 2026.
• Vanguard Capital Management, Schedule 13G, UnitedHealth Group Incorporated, reporting holdings as of 31 March 2026 — sec.gov EDGAR — retrieved 11 September 2026.

Directors and officers of UnitedHealth Group Incorporated

UnitedHealth Group Incorporated’s most recent Form 10-K, filed with the SEC on 2 March 2026 for the year ended 31 December 2025, names seven executive officers under Section 16 of the Securities Exchange Act: Stephen Hemsley (Chair and Chief Executive Officer), Wayne DeVeydt (Chief Financial Officer), Dr. Patrick Conway (Chief Executive Officer, Optum), Timothy Noel (Chief Executive Officer, UnitedHealthcare), Erin McSweeney (Executive Vice President and Chief People Officer), Christopher Zaetta (Executive Vice President, Chief Legal Officer and Corporate Secretary) and Thomas Roos (Senior Vice President and Chief Accounting Officer). This SEC disclosure reflects current officers only and does not itemise historical appointment or resignation dates for prior office-holders. Separately, Minnesota state registration records associated with UnitedHealth Group Incorporated include additional names tied to earlier company filings, including one identified only as an original incorporator, which do not reflect the company’s current executive leadership. Nationality and country of residence are not disclosed for any officer in either the SEC filings or the state registration record reviewed.

Recent officer changes

• Stephen Hemsley was appointed Chair and Chief Executive Officer effective 13 May 2025, succeeding Andrew Witty. Source: UnitedHealth Group press release, “UnitedHealth Group Announces Leadership Transition,” 13 May 2025.
• Wayne DeVeydt was appointed Chief Financial Officer effective 2 September 2025, succeeding John F. Rex, who moved to a strategic adviser role. Source: UnitedHealth Group press release, 31 July 2025.
• Sandeep Dadlani, previously Executive Vice President and Chief Digital and Technology Officer, was named Chief Executive Officer of Optum Insight in September 2025. Source: UnitedHealth Group leadership announcements, September 2025, as reported by Healthcare Dive.

Data availability

SEC disclosure of UnitedHealth Group Incorporated’s Section 16 executive officers is current and refreshed with each annual 10-K and related 8-K filings; it does not constitute a historical register of every past officer. The Minnesota business registration record includes some officer-style entries with no appointment or resignation dates that could not be confirmed as reflecting the company’s present-day leadership.

Sources

• UnitedHealth Group Incorporated, Form 10-K for the year ended 31 December 2025, filed 2 March 2026, SEC EDGAR (CIK 0000731766) — retrieved 11 September 2026.
• UnitedHealth Group, “UnitedHealth Group Announces Leadership Transition,” press release, 13 May 2025 — unitedhealthgroup.com/newsroom — retrieved 11 September 2026.
• UnitedHealth Group, “UnitedHealth Group Announces Changes to Leadership Team,” press release, 31 July 2025 — unitedhealthgroup.com/newsroom — retrieved 11 September 2026.

Group structure of UnitedHealth Group Incorporated

UnitedHealth Group Incorporated is a publicly traded, NYSE-listed company and the ultimate parent of its corporate group; no controlling parent company is identified in SEC filings or in state registry data. The company’s Form 10-K for the year ended 31 December 2025 (Exhibit 21.1, filed 2 March 2026) lists ten significant subsidiaries incorporated principally in Delaware, together with entities organised in Minnesota, Connecticut and Texas, operating under the company’s two principal businesses, UnitedHealthcare and Optum. The exhibit does not state ownership percentages for these entities or specify whether each is held directly or indirectly, and it excludes subsidiaries that do not meet SEC significance thresholds, so it should not be read as a complete corporate tree. The registry-supplied group-structure data available elsewhere on this profile reports no parent or subsidiary linkage for this company; that appears to reflect a gap in the underlying registry source rather than the absence of a corporate group, given the subsidiaries verified below as of 31 December 2025.

Verified corporate relationships

Recent structural changes

• Acquisition: UnitedHealth Group Incorporated’s Optum business completed its acquisition of Amedisys, Inc., a home health and hospice provider, in August 2025, following a U.S. Department of Justice antitrust settlement. Source: Home Health Care News / Hospice News reporting; Federal Register, 14 August 2025.
• Divestiture: As a condition of the Amedisys settlement, UnitedHealth Group Incorporated agreed to divest more than 160 home health and hospice locations, including a sale of 54 Tennessee, Georgia and Alabama locations to The Pennant Group for $146.5 million, announced May 2025. Source: U.S. Department of Justice / Federal Register, 14 August 2025.
• Pending disposal: In late November 2025, UnitedHealth Group Incorporated agreed to sell Banmedica, its remaining South American health insurance and provider business, to Patria Investments for approximately $1 billion. As of the most recent available reporting, the transaction remained subject to regulatory approval in Chile and Colombia and had not completed. Source: Reuters / CNBC reporting, 30 November-1 December 2025.

Data availability

Corporate-linkage information for UnitedHealth Group Incorporated is partial: SEC Exhibit 21.1 confirms significant subsidiaries but omits registration numbers, ownership percentages and direct/indirect classification, and excludes subsidiaries below SEC significance thresholds. No parent company or shareholding-based control chain above UnitedHealth Group Incorporated has been identified.

Sources

• UnitedHealth Group Incorporated, Form 10-K for the year ended 31 December 2025, Exhibit 21.1, filed 2 March 2026, SEC EDGAR (CIK 0000731766) — retrieved 11 September 2026.
• Federal Register, “United States, et al. v. UnitedHealth Group Incorporated, et al.; Proposed Final Judgment and Competitive Impact Statement,” 14 August 2025 — retrieved 11 September 2026.
• Reuters / CNBC, reporting on UnitedHealth Group’s agreement to sell Banmedica to Patria Investments, 30 November-1 December 2025 — retrieved 11 September 2026.